NOVARTIS | SIROHIA & SONS | NOVARTIS/ SIROHIA & SONS |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 27.3 | - | - | View Chart |
P/BV | x | 3.4 | 0.2 | 1,580.4% | View Chart |
Dividend Yield | % | 4.5 | 0.0 | - |
NOVARTIS SIROHIA & SONS |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
NOVARTIS Mar-23 |
SIROHIA & SONS Mar-23 |
NOVARTIS/ SIROHIA & SONS |
5-Yr Chart Click to enlarge
|
||
High | Rs | 763 | 9 | 8,813.5% | |
Low | Rs | 554 | 9 | 6,397.2% | |
Sales per share (Unadj.) | Rs | 153.4 | 0 | - | |
Earnings per share (Unadj.) | Rs | 41.9 | -0.1 | -29,021.3% | |
Cash flow per share (Unadj.) | Rs | 44.3 | -0.1 | -32,949.1% | |
Dividends per share (Unadj.) | Rs | 47.50 | 0 | - | |
Avg Dividend yield | % | 7.2 | 0 | - | |
Book value per share (Unadj.) | Rs | 314.2 | 27.4 | 1,147.7% | |
Shares outstanding (eoy) | m | 24.69 | 10.26 | 240.6% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 4.3 | 0 | - | |
Avg P/E ratio | x | 15.7 | -60.0 | -26.2% | |
P/CF ratio (eoy) | x | 14.9 | -64.4 | -23.1% | |
Price / Book Value ratio | x | 2.1 | 0.3 | 663.0% | |
Dividend payout | % | 113.5 | 0 | - | |
Avg Mkt Cap | Rs m | 16,262 | 89 | 18,311.0% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 356 | 1 | 63,642.9% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 3,787 | 0 | - | |
Other income | Rs m | 581 | 4 | 15,132.8% | |
Total revenues | Rs m | 4,369 | 4 | 113,763.0% | |
Gross profit | Rs m | 651 | -5 | -12,588.0% | |
Depreciation | Rs m | 61 | 0 | 60,600.0% | |
Interest | Rs m | 18 | 0 | - | |
Profit before tax | Rs m | 1,154 | -1 | -80,685.3% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 120 | 0 | 240,400.0% | |
Profit after tax | Rs m | 1,034 | -1 | -69,837.8% | |
Gross profit margin | % | 17.2 | 0 | - | |
Effective tax rate | % | 10.4 | -3.3 | -315.0% | |
Net profit margin | % | 27.3 | 0 | - |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 7,861 | 240 | 3,274.4% | |
Current liabilities | Rs m | 2,683 | 0 | 638,714.3% | |
Net working cap to sales | % | 136.7 | 0 | - | |
Current ratio | x | 2.9 | 571.6 | 0.5% | |
Inventory Days | Days | 1,201 | 0 | - | |
Debtors Days | Days | 35 | 0 | - | |
Net fixed assets | Rs m | 12,656 | 41 | 30,740.6% | |
Share capital | Rs m | 123 | 103 | 120.3% | |
"Free" reserves | Rs m | 7,634 | 178 | 4,280.8% | |
Net worth | Rs m | 7,757 | 281 | 2,761.8% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 20,517 | 281 | 7,295.4% | |
Interest coverage | x | 66.9 | 0 | - | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 0.2 | 0 | - | |
Return on assets | % | 5.1 | -0.5 | -973.9% | |
Return on equity | % | 13.3 | -0.5 | -2,529.8% | |
Return on capital | % | 15.1 | -0.5 | -2,961.5% | |
Exports to sales | % | 2.1 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | 80 | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 80 | 0 | - | |
Fx outflow | Rs m | 946 | 0 | - | |
Net fx | Rs m | -866 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 448 | 0 | 194,782.6% | |
From Investments | Rs m | -1,533 | NA | - | |
From Financial Activity | Rs m | -305 | NA | 63,500.0% | |
Net Cashflow | Rs m | -1,389 | 0 | 555,720.0% |
Indian Promoters | % | 0.0 | 50.1 | - | |
Foreign collaborators | % | 70.7 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.7 | 0.0 | - | |
FIIs | % | 0.2 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 29.3 | 49.9 | 58.8% | |
Shareholders | 41,239 | 142 | 29,041.5% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare NOVARTIS With: ADANI ENTERPRISES REDINGTON MMTC SIRCA PAINTS INDIA
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Novartis | SIROHIA & SONS | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 0.87% | -4.90% | 0.45% |
1-Month | 0.85% | -5.21% | 2.55% |
1-Year | 81.60% | -35.97% | 56.14% |
3-Year CAGR | 17.51% | -13.87% | 15.22% |
5-Year CAGR | 8.12% | -8.57% | 19.63% |
* Compound Annual Growth Rate
Here are more details on the Novartis share price and the SIROHIA & SONS share price.
Moving on to shareholding structures...
The promoters of Novartis hold a 70.7% stake in the company. In case of SIROHIA & SONS the stake stands at 50.1%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Novartis and the shareholding pattern of SIROHIA & SONS.
Finally, a word on dividends...
In the most recent financial year, Novartis paid a dividend of Rs 47.5 per share. This amounted to a Dividend Payout ratio of 113.5%.
SIROHIA & SONS paid Rs 0.0, and its dividend payout ratio stood at -0.0%.
You may visit here to review the dividend history of Novartis, and the dividend history of SIROHIA & SONS.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.